Insider · CIK 0001686223

Baluch Khoso

Reports to the SEC for 3 companies · VERO BEACH, FL

sec.gov

Transactions

Companies

Filings

CIK

0001686223

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-26	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+33.5K sh	—	—	38,749
2026-06-26	PCSAProcessa Pharmaceuticals, Inc. · Restricted StockM Exercise/Conversion	Director	MExercise/Conversion	−203 sh	—	—	5,249
2026-06-26	PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+203 sh	—	—	2,528
2026-03-31	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+2,269 sh	$2.54	+$5,751.915	2,325
2025-10-01	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+100K sh	—	—	100,000
2025-10-01	PCSAProcessa Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+300K sh	—	—	300,000
2025-08-11	LGVNLongeveron Inc. · Warrant (right to buy)P Purchase	Director	PPurchase	+29.4K sh	—	—	29,415
2025-08-11	LGVNLongeveron Inc.P Purchase	Director	PPurchase	+11.8K sh	—	—	52,516
2025-07-24	PCSAProcessa Pharmaceuticals, Inc. · Restricted StockA Award	Director	AAward	+175K sh	—	—	206,505
2025-07-15	LGVNLongeveron Inc.A Award	Director	AAward	+17K sh	—	—	40,750
2024-12-02	LGVNLongeveron Inc.S Sale	Director	SSale	−1,250 sh	$2.07	−$2,588.125	23,750
2024-09-03	PCSAProcessa Pharmaceuticals, Inc. · Restricted StockA Award	Director	AAward	+31.2K sh	—	—	31,206
2024-09-03	PCSAProcessa Pharmaceuticals, Inc. · Restricted StockA Award	Director	AAward	+31.2K sh	—	—	36,275
2024-08-15	LGVNLongeveron Inc.A Award	Director	AAward	+23.5K sh	—	—	38,375
2024-06-09	LGVNLongeveron Inc.F Tax Payment	Director	FTax Payment	−125 sh	$1.06	−$132.5	14,875
2023-12-29	LGVNLongeveron Inc.P Purchase	Director	PPurchase	+8,322 sh	$1.43	+$11.9K	15,000
2023-12-28	LGVNLongeveron Inc.P Purchase	Director	PPurchase	+1,678 sh	$1.40	+$2,341.985	6,678
2023-12-21	LGVNLongeveron Inc. · Stock Option (Right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2023-06-27	PCSAProcessa Pharmaceuticals, Inc. · Restricted StockA Award	Director	AAward	+101K sh	—	—	101,365
2023-06-27	PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15.5K sh	—	—	27,955
2023-06-27	PCSAProcessa Pharmaceuticals, Inc. · Restricted StockM Exercise/Conversion	Director	MExercise/Conversion	−15.5K sh	—	—	0
2023-06-09	LGVNLongeveron Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-02-09	PCSAProcessa Pharmaceuticals, Inc.A Award	Director	AAward	+12.5K sh	$0.80	+$10K	12,500
2022-07-12	PCSAProcessa Pharmaceuticals, Inc. · Restricted StockA Award	Director	AAward	+19.1K sh	—	—	19,091
2021-01-11	CRMDCorMedix Inc. · Stock Option (Right to Buy Common Stock)A Award	Director, Chief Executive Officer	AAward	+320K sh	—	—	320,000
2020-08-13	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4,830 sh	$4.14	+$20K	60,905
2020-03-18	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,500 sh	$2.61	+$9,135	56,075
2020-02-25	CRMDCorMedix Inc. · Stock Option (Right to Buy Common Stock)A Award	Director, Chief Executive Officer	AAward	+101K sh	$5.63	+$567K	100,630
2019-09-26	CRMDCorMedix Inc. · Stock Option (Right to Buy Common Stock)A Award	Director, Chief Executive Officer	AAward	+120K sh	—	—	120,000
2019-03-26	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,500 sh	$7.55	+$18.9K	52,575
2019-01-10	CRMDCorMedix Inc. · Stock Option (Right to Buy Common Stock)A Award	Director, Chief Executive Officer	AAward	+400K sh	—	—	400,000
2018-11-27	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+21.5K sh	$1.21	+$26K	250,373
2018-11-26	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,500 sh	$1.28	+$4,480	228,873
2018-02-16	CRMDCorMedix Inc. · Stock Option (Right to Buy Common Stock)A Award	Director, Chief Executive Officer	AAward	+225K sh	—	—	225,000
2017-12-12	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+104K sh	$0.48	+$50K	225,373
2017-08-18	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+36.2K sh	$0.41	+$15K	121,207
2017-05-17	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+75K sh	$0.47	+$35.6K	85,000
2016-12-09	CRMDCorMedix Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$1.77	+$17.7K	10,000
2016-10-03	CRMDCorMedix Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.25M sh	—	—	1,250,000
2016-10-03	CRMDCorMedix Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000
2016-10-03	CRMDCorMedix Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000
2016-10-03	CRMDCorMedix Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+1.25M sh	—	—	1,250,000
2016-10-03	CRMDCorMedix Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000
2016-10-03	CRMDCorMedix Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000

Recent filings

Accepted (ET)
Jul 284
Baluch Khoso0000897069-26-001546
SEC(opens sec.gov)
Jun 304
Baluch Khoso0000897069-26-001466
SEC(opens sec.gov)
Apr 14
Baluch Khoso0000897069-26-000741
SEC(opens sec.gov)
Oct 34
Baluch Khoso0000897069-25-001559
SEC(opens sec.gov)
Sep 184/A
Baluch Khoso0000897069-25-001488
SEC(opens sec.gov)
Aug 134
Baluch Khoso0001214659-25-012013
SEC(opens sec.gov)
Jul 284
Baluch Khoso0000897069-25-001209
SEC(opens sec.gov)
Jul 174
Baluch Khoso0001214659-25-010570
SEC(opens sec.gov)
Dec 44
Baluch Khoso0001214659-24-019977
SEC(opens sec.gov)
Sep 184
Baluch Khoso0000897069-24-001860
SEC(opens sec.gov)
Aug 194
Baluch Khoso0001214659-24-014990
SEC(opens sec.gov)
Jun 114
Baluch Khoso0001214659-24-010840
SEC(opens sec.gov)
Jan 24
Baluch Khoso0001214659-24-000079
SEC(opens sec.gov)
Dec 264
Baluch Khoso0001214659-23-016872
SEC(opens sec.gov)
Jul 244
Baluch Khoso0000897069-23-001000
SEC(opens sec.gov)

Companies

Address

C/O PROCESSA PHARMACEUTICALS, INC. 601 21ST STREET SUITE 300

VERO BEACH, FL, 32960